Epidemiology of heart failure with preserved ejection fraction (original) (raw)

• Heidenreich, P. A. et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ. Heart Fail. 6, 606–619 (2013).
  CAS PubMed PubMed Central Google Scholar
• Ponikowski, P. et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 37, 2129–2200 (2016).
  PubMed Google Scholar
• Yancy, C. W. et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128, e240–e327 (2013).
  PubMed Google Scholar
• Heidenreich, P. A. et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123, 933–944 (2011).
  PubMed Google Scholar
• Colby, S. L. & Ortman, J. M. Projections of the size and composition of the U.S. population 2014 to 2060. U.S. Department of Commerce: Economics and Statistics Administration: U.S. Census Bureau https://www.census.gov/content/dam/Census/library/publications/2015/demo/p25-1143.pdf (2015).
  Google Scholar
• Finkelstein, E. A. et al. Obesity and severe obesity forecasts through 2030. Am. J. Prev. Med. 42, 563–570 (2012).
  PubMed Google Scholar
• Boyle, J. P., Thompson, T. J., Gregg, E. W., Barker, L. E. & Williamson, D. F. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul. Health Metr. 8, 29 (2010).
  PubMed PubMed Central Google Scholar
• Borlaug, B. A. & Redfield, M. M. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation 123, 2006–2013 (2011).
  PubMed PubMed Central Google Scholar
• Paulus, W. J. & Tschope, C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J. Am. Coll. Cardiol. 62, 263–271 (2013).
  PubMed Google Scholar
• McMurray, J. J. Clinical practice. Systolic heart failure. N. Engl. J. Med. 362, 228–238 (2010).
  CAS PubMed Google Scholar
• Redfield, M. M. Heart failure with preserved ejection fraction. N. Engl. J. Med. 375, 1868–1877 (2016).
  PubMed Google Scholar
• Dunlay, S. M., Roger, V. L., Weston, S. A., Jiang, R. & Redfield, M. M. Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circ. Heart Fail. 5, 720–726 (2012).
  PubMed PubMed Central Google Scholar
• Lam, C. S. et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 115, 1982–1990 (2007).
  PubMed PubMed Central Google Scholar
• Maurer, M. S. et al. Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study. J. Am. Coll. Cardiol. 49, 972–981 (2007).
  PubMed Google Scholar
• Anjan, V. Y. et al. Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction. Am. J. Cardiol. 110, 870–876 (2012).
  CAS PubMed PubMed Central Google Scholar
• Borlaug, B. A., Nishimura, R. A., Sorajja, P., Lam, C. S. & Redfield, M. M. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ. Heart Fail. 3, 588–595 (2010).
  PubMed PubMed Central Google Scholar
• Obokata, M. et al. The role of diastolic stress testing in the evaluation for HFpEF: a simultaneous invasive-echocardiographic study. Circulation 135, 825–838 (2016).
  PubMed PubMed Central Google Scholar
• Costello-Boerrigter, L. C. et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J. Am. Coll. Cardiol. 47, 345–353 (2006).
  CAS PubMed PubMed Central Google Scholar
• Redfield, M. M. et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J. Am. Coll. Cardiol. 40, 976–982 (2002).
  CAS PubMed Google Scholar
• Richards, M. et al. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure). JACC Heart Fail. 1, 192–199 (2013).
  PubMed Google Scholar
• Redfield, M. M. et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289, 194–202 (2003).
  PubMed Google Scholar
• McKee, P. A., Castelli, W. P., McNamara, P. M. & Kannel, W. B. The natural history of congestive heart failure: the Framingham study. N. Engl. J. Med. 285, 1441–1446 (1971).
  CAS PubMed Google Scholar
• Eriksson, H. et al. Cardiac and pulmonary causes of dyspnoea — validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. Eur. Heart J. 8, 1007–1014 (1987).
  CAS PubMed Google Scholar
• Carlson, K. J., Lee, D. C., Goroll, A. H., Leahy, M. & Johnson, R. A. An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients. J. Chron. Dis. 38, 733–739 (1985).
  CAS PubMed Google Scholar
• Di Bari, M. et al. The diagnosis of heart failure in the community. Comparative validation of four sets of criteria in unselected older adults: the ICARe Dicomano Study. J. Am. Coll. Cardiol. 44, 1601–1608 (2004).
  PubMed Google Scholar
• Bursi, F. et al. Systolic and diastolic heart failure in the community. JAMA 296, 2209–2216 (2006).
  CAS PubMed Google Scholar
• Pakhomov, S. V., Buntrock, J. & Chute, C. G. Prospective recruitment of patients with congestive heart failure using an ad-hoc binary classifier. J. Biomed. Inform. 38, 145–153 (2005).
  PubMed Google Scholar
• Bielinski, S. J. et al. A robust e-epidemiology tool in phenotyping heart failure with differentiation for preserved and reduced ejection fraction: the Electronic Medical Records and Genomics (eMERGE) network. J. Cardiovasc. Transl. Res. 8, 475–483 (2015).
  PubMed PubMed Central Google Scholar
• Blecker, S. et al. Comparison of approaches for heart failure case identification from electronic health record data. JAMA Cardiol. 1, 1014–1020 (2016).
  PubMed PubMed Central Google Scholar
• Ceia, F. et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur. J. Heart Fail. 4, 531–539 (2002).
  PubMed Google Scholar
• Brouwers, F. P. et al. Incidence and epidemiology of new onset heart failure with preserved versus reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur. Heart J. 34, 1424–1431 (2013).
  CAS PubMed Google Scholar
• Gottdiener, J. S. et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann. Intern. Med. 137, 631–639 (2002).
  PubMed Google Scholar
• Philbin, E. F., Rocco, T. A. Jr, Lindenmuth, N. W., Ulrich, K. & Jenkins, P. L. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am. J. Med. 109, 605–613 (2000).
  CAS PubMed Google Scholar
• Owan, T. E. et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 355, 251–259 (2006).
  CAS PubMed Google Scholar
• Yancy, C. W. et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J. Am. Coll. Cardiol. 47, 76–84 (2006).
  PubMed Google Scholar
• Gurwitz, J. H. et al. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am. J. Med. 126, 393–400 (2013).
  PubMed PubMed Central Google Scholar
• Gustafsson, F. et al. Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur. Heart J. 24, 863–870 (2003).
  PubMed Google Scholar
• Lenzen, M. J. et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur. Heart J. 25, 1214–1220 (2004).
  CAS PubMed Google Scholar
• MacCarthy, P. A. et al. Prognosis in heart failure with preserved left ventricular systolic function: prospective cohort study. BMJ 327, 78–79 (2003).
  PubMed PubMed Central Google Scholar
• Bhatia, R. S. et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N. Engl. J. Med. 355, 260–269 (2006).
  CAS PubMed Google Scholar
• Gerber, Y. et al. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern. Med. 175, 996–1004 (2015).
  PubMed PubMed Central Google Scholar
• St Sauver, J. L. et al. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin. Proc. 87, 151–160 (2012).
  PubMed PubMed Central Google Scholar
• Ho, J. E. et al. Predicting heart failure with preserved and reduced ejection fraction: the International Collaboration on Heart Failure Subtypes. Circ. Heart Fail. 9, e003116 (2016).
  PubMed Google Scholar
• Devereux, R. B. et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am. J. Cardiol. 86, 1090–1096 (2000).
  CAS PubMed Google Scholar
• Fonarow, G. C. et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry. J. Am. Coll. Cardiol. 50, 768–777 (2007).
  PubMed Google Scholar
• Ho, J. E. et al. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ. Heart Fail. 6, 279–286 (2013).
  PubMed Google Scholar
• Senni, M. et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 98, 2282–2289 (1998).
  CAS PubMed Google Scholar
• Lee, D. S. et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation 119, 3070–3077 (2009).
  PubMed PubMed Central Google Scholar
• Silverman, M. G. et al. Impact of race, ethnicity, and multimodality biomarkers on the incidence of new-onset heart failure with preserved ejection fraction (from the Multi-Ethnic Study of Atherosclerosis). Am. J. Cardiol. 117, 1474–1481 (2016).
  PubMed PubMed Central Google Scholar
• Eaton, C. B. et al. Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women. Circ. Heart Fail. 9, e002883 (2016).
  PubMed PubMed Central Google Scholar
• Meta-analysis Global Group in Chronic Heart Failure. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur. Heart J. 33, 1750–1757 (2012).
• Lam, C. S., Donal, E., Kraigher-Krainer, E. & Vasan, R. S. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur. J. Heart Fail. 13, 18–28 (2011).
  PubMed Google Scholar
• Zakeri, R., Chamberlain, A. M., Roger, V. L. & Redfield, M. M. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation 128, 1085–1093 (2013).
  PubMed PubMed Central Google Scholar
• Chamberlain, A. M. et al. Multimorbidity in heart failure: a community perspective. Am. J. Med. 128, 38–45 (2015).
  PubMed Google Scholar
• Shah, S. J., Katz, D. H. & Deo, R. C. Phenotypic spectrum of heart failure with preserved ejection fraction. Heart Fail. Clin. 10, 407–418 (2014).
  PubMed PubMed Central Google Scholar
• Shah, S. J. et al. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation 134, 73–90 (2016).
  PubMed PubMed Central Google Scholar
• Kao, D. P. et al. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response. Eur. J. Heart Fail. 17, 925–935 (2015).
  PubMed Google Scholar
• Lindman, B. R. et al. Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study. J. Am. Coll. Cardiol. 64, 541–549 (2014).
  PubMed PubMed Central Google Scholar
• Shah, S. J. et al. Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation 131, 269–279 (2015).
  PubMed Google Scholar
• Gonzalez-Lopez, E. et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur. Heart J. 36, 2585–2594 (2015).
  CAS PubMed Google Scholar
• Mohammed, S. F. et al. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail. 2, 113–122 (2014).
  PubMed PubMed Central Google Scholar
• Lam, C. S. et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J. Am. Coll. Cardiol. 53, 1119–1126 (2009).
  PubMed PubMed Central Google Scholar
• Bursi, F. et al. Pulmonary pressures and death in heart failure: a community study. J. Am. Coll. Cardiol. 59, 222–231 (2012).
  PubMed PubMed Central Google Scholar
• Leung, C. C., Moondra, V., Catherwood, E. & Andrus, B. W. Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction. Am. J. Cardiol. 106, 284–286 (2010).
  PubMed Google Scholar
• Adamson, P. B. et al. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. Circ. Heart Fail. 7, 935–944 (2014).
  PubMed Google Scholar
• Melenovsky, V., Hwang, S. J., Lin, G., Redfield, M. M. & Borlaug, B. A. Right heart dysfunction in heart failure with preserved ejection fraction. Eur. Heart J. 35, 3452–3462 (2014).
  CAS PubMed PubMed Central Google Scholar
• Guazzi, M., Vicenzi, M., Arena, R. & Guazzi, M. D. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 124, 164–174 (2011).
  CAS PubMed Google Scholar
• Hoendermis, E. S. et al. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial. Eur. Heart J. 36, 2565–2573 (2015).
  CAS PubMed Google Scholar
• Opitz, C. F. et al. Pre-capillary, combined, and post-capillary pulmonary hypertension: a pathophysiological continuum. J. Am. Coll. Cardiol. 68, 368–378 (2016).
  PubMed Google Scholar
• Shapiro, B. P., McGoon, M. D. & Redfield, M. M. Unexplained pulmonary hypertension in elderly patients. Chest 131, 94–100 (2007).
  PubMed Google Scholar
• Fawzy, M. E. et al. Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing mitral balloon valvotomy. J. Heart Valve Dis. 13, 942–947 (2004).
  PubMed Google Scholar
• Edelmann, F. et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA 309, 781–791 (2013).
  CAS PubMed Google Scholar
• Redfield, M. M. et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 309, 1268–1277 (2013).
  CAS PubMed Google Scholar
• Yusuf, S. et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362, 777–781 (2003).
  CAS PubMed Google Scholar
• Zile, M. R. et al. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation 121, 1393–1405 (2010).
  PubMed Google Scholar
• Massie, B. M. et al. Irbesartan in patients with heart failure and preserved ejection fraction. N. Engl. J. Med. 359, 2456–2467 (2008).
  CAS PubMed Google Scholar
• Cleland, J. G. et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur. Heart J. 27, 2338–2345 (2006).
  CAS PubMed Google Scholar
• Pitt, B. et al. Spironolactone for heart failure with preserved ejection fraction. N. Engl. J. Med. 370, 1383–1392 (2014).
  CAS PubMed Google Scholar
• Perez de Isla, L. et al. Diastolic heart failure in the elderly: in-hospital and long-term outcome after the first episode. Int. J. Cardiol. 134, 265–270 (2009).
  PubMed Google Scholar
• Tribouilloy, C. et al. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur. Heart J. 29, 339–347 (2008).
  PubMed Google Scholar
• Henkel, D. M., Redfield, M. M., Weston, S. A., Gerber, Y. & Roger, V. L. Death in heart failure: a community perspective. Circ. Heart Fail. 1, 91–97 (2008).
  PubMed PubMed Central Google Scholar
• Somaratne, J. B. et al. The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis. Eur. J. Heart Fail. 11, 855–862 (2009).
  PubMed Google Scholar
• Steinberg, B. A. et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation 126, 65–75 (2012).
  PubMed Google Scholar
• Murad, K. et al. Burden of comorbidities and functional and cognitive impairments in elderly patients at the initial diagnosis of heart failure and their impact on total mortality: the Cardiovascular Health Study. JACC Heart Fail. 3, 542–550 (2015).
  PubMed PubMed Central Google Scholar
• Mohammed, S. F. et al. Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Circulation 130, 2310–2320 (2014).
  PubMed PubMed Central Google Scholar
• Aschauer, S. et al. Modes of death in patients with heart failure and preserved ejection fraction. Int. J. Cardiol. 228, 422–426 (2017).
  PubMed Google Scholar
• Senni, M. et al. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo versus worsening) and ejection fraction. Results from IN-HF Outcome Registry. Int. J. Cardiol. 173, 163–169 (2014).
  PubMed Google Scholar
• Cheng, R. K. et al. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Am. Heart J. 168, 721–730 (2014).
  PubMed Google Scholar
• Vaduganathan, M. et al. Mode of death in heart failure with preserved ejection fraction. J. Am. Coll. Cardiol. 69, 556–569 (2017).
  PubMed Google Scholar
• Lee, D. S. et al. A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction. Circ. Heart Fail. 4, 36–43 (2011).
  PubMed Google Scholar
• Ahmed, A. et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 114, 397–403 (2006).
  CAS PubMed PubMed Central Google Scholar
• Vaduganathan, M., Patel, R. B., Shah, S. J. & Butler, J. Sudden cardiac death in heart failure with preserved ejection fraction: a target for therapy? Heart Fail. Rev. 21, 455–462 (2016).
  CAS PubMed Google Scholar
• Levy, W. C. et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113, 1424–1433 (2006).
  PubMed Google Scholar
• Shadman, R. et al. A novel method to predict the proportional risk of sudden cardiac death in heart failure: derivation of the Seattle Proportional Risk Model. Heart Rhythm 12, 2069–2077 (2015).
  PubMed Google Scholar
• Nichols, G. A., Reynolds, K., Kimes, T. M., Rosales, A. G. & Chan, W. W. Comparison of risk of re-hospitalization, all-cause mortality, and medical care resource utilization in patients with heart failure and preserved versus reduced ejection fraction. Am. J. Cardiol. 116, 1088–1092 (2015).
  PubMed Google Scholar
• Bello, N. A. et al. Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circ. Heart Fail. 7, 590–595 (2014).
  PubMed PubMed Central Google Scholar
• Carson, P. E. et al. The hospitalization burden and post-hospitalization mortality risk in heart failure with preserved ejection fraction: results from the I-PRESERVE trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). JACC Heart Fail. 3, 429–441 (2015).
  PubMed Google Scholar
• Vader, J. M. et al. Timing and causes of readmission after acute heart failure hospitalization — insights from the Heart Failure Network Trials. J. Card. Fail. 22, 875–883 (2016).
  PubMed PubMed Central Google Scholar
• Dunlay, S. M. et al. Hospitalizations after heart failure diagnosis a community perspective. J. Am. Coll. Cardiol. 54, 1695–1702 (2009).
  PubMed PubMed Central Google Scholar
• Lewis, E. F. et al. Impact of spironolactone on longitudinal changes in health-related quality of life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist trial. Circ. Heart Fail. 9, e001937 (2016).
  CAS PubMed Google Scholar
• Joseph, S. M. et al. Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction. Circ. Heart Fail. 6, 1139–1146 (2013).
  PubMed PubMed Central Google Scholar
• Bekfani, T. et al. Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle strength, exercise capacity and quality of life. Int. J. Cardiol. 222, 41–46 (2016).
  PubMed Google Scholar
• O'Meara, E. et al. Patient perception of the effect of treatment with candesartan in heart failure: results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur. J. Heart Fail. 7, 650–656 (2005).
  CAS PubMed Google Scholar
• Nolte, K. et al. Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial. Eur. J. Prev. Cardiol. 22, 582–593 (2015).
  PubMed Google Scholar
• Pandey, A. et al. Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circ. Heart Fail. 8, 33–40 (2015).
  PubMed Google Scholar
• Austin, B. A. et al. Systolic function as a predictor of mortality and quality of life in long-term survivors with heart failure. Clin. Cardiol. 31, 119–124 (2008).
  PubMed PubMed Central Google Scholar
• Joyce, E. et al. Variable contribution of heart failure to quality of life in ambulatory heart failure with reduced, better, or preserved ejection fraction. JACC Heart Fail. 4, 184–193 (2016).
  PubMed Google Scholar
• Santhanakrishnan, R. et al. The Singapore Heart Failure Outcomes and Phenotypes (SHOP) study and Prospective Evaluation of Outcome in Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction (PEOPLE) study: rationale and design. J. Card. Fail. 19, 156–162 (2013).
  PubMed Google Scholar
• Tschope, C. et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111, 879–886 (2005).
  CAS PubMed Google Scholar
• Rosamond, W. D. et al. Classification of heart failure in the Atherosclerosis Risk in Communities (ARIC) study: a comparison of diagnostic criteria. Circ. Heart Fail. 5, 152–159 (2012).
  PubMed PubMed Central Google Scholar
• Klapholz, M. et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J. Am. Coll. Cardiol. 43, 1432–1438 (2004).
  PubMed Google Scholar
• Yip, G. W., Ho, P. P., Woo, K. S. & Sanderson, J. E. Comparison of frequencies of left ventricular systolic and diastolic heart failure in Chinese living in Hong Kong. Am. J. Cardiol. 84, 563–567 (1999).
  CAS PubMed Google Scholar
• Psaty, B. M. et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann. Epidemiol. 5, 270–277 (1995).
  CAS PubMed Google Scholar
• Dawber, T. R., Kannel, W. B. & Lyell, L. P. An approach to longitudinal studies in a community: the Framingham Study. Ann. NY Acad. Sci. 107, 539–556 (1963).
  CAS PubMed Google Scholar
• Kannel, W. B., Feinleib, M., McNamara, P. M., Garrison, R. J. & Castelli, W. P. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am. J. Epidemiol. 110, 281–290 (1979).
  CAS PubMed Google Scholar
• Diercks, G. F. et al. Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT]). Am. J. Cardiol. 86, 635–638 (2000).
  CAS PubMed Google Scholar
• Solomon, S. D. et al. Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 110, 2180–2183 (2004).
  CAS PubMed Google Scholar
• Adabag, S., Smith, L. G., Anand, I. S., Berger, A. K. & Luepker, R. V. Sudden cardiac death in heart failure patients with preserved ejection fraction. J. Card. Fail. 18, 749–754 (2012).
  PubMed Google Scholar
• Hamaguchi, S. et al. Mode of death in patients with heart failure and reduced versus preserved ejection fraction: report from the registry of hospitalized heart failure patients. Circ. J. 76, 1662–1669 (2012).
  PubMed Google Scholar